Medscape

Intra-Aortic Balloon Counterpulsation as a Bridge to Heart Transplantation Does Not Impair Long-Term Survival

Aims There are few studies of the use of intra-aortic balloon pump (IABP) treatment as a bridge to heart transplantation (HTx). This is the first study to compare long-term clinical and haemodynamic ...
Medscape

The Intra-aortic Balloon Pump in High-risk Percutaneous Coronary Intervention

IABP systems are typically inserted within the multidisciplinary environment that is the cardiac catheterization laboratory. The specific role of the physiologist during IABP insertion is to ensure ...
Monthly Prescribing Reference

No 30-Day Mortality Reduction With Intraaortic Balloon Pump

No 30-Day Mortality Reduction With Intraaortic Balloon Pump In patients with cardiogenic shock complicating acute myocardial infarction, for whom early revascularization strategy is planned, ...
FiercePharma

--Study Results Demonstrating Trend Toward Improvement in 30-Day All-Cause Mortality Presented at ESC Congress 2012-

MUNICH and WAYNE, N.J., Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large, ...
Healio

CRISP AMI: Intra-aortic balloon pump counterpulsation failed to reduce infarct size in STEMI patients

Please provide your email address to receive an email when new articles are posted on . Infarct size as measured by MRI does not reduce when intra-aortic balloon pump counterpulsation is used before ...
Forbes

ESC: Trial Finds No Benefit For Intraaortic Balloon Counterpulsation In Cardiogenic Shock

Despite a lack of evidence, circulatory support with intraaortic balloon counterpulation (IABP) has a class 1 recommendation in the guidelines and is often used in patients in cardiogenic shock ...
PR Newswire

MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients

MUNICH and WAYNE, New Jersey, Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large ...
Nature

Are peripheral arterial changes during enhanced external counterpulsation necessary for and/or evidence of an adequate cardiovascular response?

Enhanced external counterpulsation (EECP) is a noninvasive counterpulsation technique that reduces angina episodes and nitrate usage in patients with coronary artery disease (CAD) who experience ...